For research & educational purposes only. This article is a neutral, procedural reference for laboratory / in-vitro research handling — not medical advice or a usage recommendation. These materials are not for human or animal consumption.
What CJC-1295 + Ipamorelin is
This is a two-in-one research blend: CJC-1295 (a copy of the 'release growth hormone' signal, GHRH) plus Ipamorelin (which pushes the same system from a different angle). It is supplied as an analytical-grade reference material for laboratory research.
What it does — in plain terms
The body's growth-hormone system has more than one 'go' button. CJC-1295 presses one of them (the GHRH signal); Ipamorelin presses another (the ghrelin/secretagogue signal). Pairing them is a common research design, because pressing two buttons at once is a cleaner way to study how the system responds. Ipamorelin is also of interest because it's 'selective' — it nudges growth hormone without stirring up other hormones as much.
Here's where CJC-1295 + Ipamorelin actually shows up in the published research:
- How the body releases growth hormone
- Comparing the two 'release' pathways
- Endocrine signaling research
Plain-language explanations describe what researchers study — not what any product does for a person, and not medical advice. Every material here is sold for laboratory research use only and is not for human or animal use.
Reconstitution reference
Standard laboratory reconstitution volumes for CJC-1295 + Ipamorelin, from the VNG Reconstitution Sheet. See the full reconstitution guide for the method and concentration math.
| Product | Vial | Bacteriostatic water | Resulting concentration |
|---|---|---|---|
| CJC-1295 + Ipamorelin | 5 mg + 5 mg | 2 mL | 5 mg/mL (of the blend) |
Published research
A selection of peer-reviewed and clinical literature indexed on PubMed. Provided so qualified researchers can locate the primary sources — inclusion here is not a claim about any product or outcome.
- Animal-model studyPhysiology & behavior · 2024
Ipamorelin and chemotherapy weight loss — animal study
View on PubMed - Peer-reviewed studyEuropean journal of endocrinology · 1998
Ipamorelin — first selective GH secretagogue
View on PubMed - Peer-reviewed reviewJournal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026
Therapeutic peptides in orthopaedics — review
View on PubMed - Animal-model studyGrowth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 1999
Ipamorelin and bone growth — rats
View on PubMed - Human clinical studyPharmaceutical research · 1999
Ipamorelin pharmacokinetics in human volunteers
View on PubMed - Peer-reviewed studyXenobiotica; the fate of foreign compounds in biological systems · 1998
Ipamorelin pharmacokinetics & nasal absorption
View on PubMed - Peer-reviewed studyBioorganic & medicinal chemistry letters · 2001
GH secretagogue hybrids of ipamorelin — chemistry
View on PubMed - Peer-reviewed studyTranslational andrology and urology · 2020
GH secretagogues and body composition — review
View on PubMed - Animal-model studyHistology and histopathology · 2002
Ipamorelin and somatotroph response — rats
View on PubMed - Animal-model studyGrowth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2001
Ipamorelin and steroid-related bone loss — rats
View on PubMed
References & resources
Related reference materials
VNG Research Team
VNG Labs supplies analytical-grade reference materials with lot-matched Certificates of Analysis. Our write-ups are neutral, source-cited references for qualified and independent researchers.
More from LearnResearch use only. Not for human consumption or veterinary use. Sold exclusively to qualified researchers for in vitro and laboratory research. These statements have not been evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. Refrigerate upon receipt. Keep in dark environment.
